“We believe that tailored navigation with mailed stool blood testing and colonoscopy materials for everyone may increase screening adherence and also reduce screening disparity,” Dr. Myer noted, adding that it appears best to offer both tests, identify the preferred test, and provide support for the performance of that preferred test.
Additional research is needed to determine how to maximize the effects of tailored navigation and to determine its impact on racial disparities in colorectal cancer outcomes, Dr. Myer said. A study similar in design to those conducted in general and African American populations is underway in a Hispanic population, he added. Dr. Myers reported having no disclosures.
